Quick verdict: ACN vs IBM in 2026

In this ACN vs IBM stock comparison for 2026, Accenture (ACN) appears to have a slight overall edge, leading on 7 of 11 comparable metrics in our scorecard. IBM emerges as the growth leader with marginally higher revenue growth and significantly better profitability margins, while ACN stands out as the value leader based on P/E and P/B ratios, and is clearly the analyst favorite with substantial projected upside. Investors seeking potential undervaluation via a Discounted Cash Flow (DCF) model might find IBM more attractive, yet ACN boasts a higher consensus price target upside. Not investment advice.

ACN vs IBM: key metrics side by side

Full side-by-side comparison of ACN and IBM across valuation, profitability, growth and analyst sentiment. Data updated 2026-04-30.

ACN vs IBM valuation comparison

When considering ACN vs IBM valuation in 2026, Accenture (ACN) generally appears to trade at more attractive multiples based on traditional metrics. ACN’s trailing P/E ratio stands at a reasonable 14.48x, significantly lower than IBM’s P/E of 19.82x. This suggests that investors are paying less for each dollar of Accenture’s earnings compared to IBM. Similarly, ACN’s Price-to-Book (P/B) ratio of 3.56x is considerably lower than IBM’s 6.46x, further indicating a potentially more favorable valuation for ACN on a book value basis. These lower multiples position ACN as a more value-oriented option for investors focused on current financial health.

However, the Discounted Cash Flow (DCF) model presents a different perspective on ACN vs IBM fundamentals and valuation. While ACN shows a DCF upside of +16.9% from its current price of $180.26 to a fair value of $210.65, IBM reveals a much more substantial DCF upside of +92.7% from its current $227.1 to a fair value of $437.54. This dramatic difference suggests that, from an intrinsic value perspective derived through future cash flow projections, IBM might be significantly more undervalued by the market despite its higher P/E and P/B ratios. Investors prioritising long-term intrinsic value might lean towards IBM, recognizing its deeper discount to its calculated fair value.

ACN vs IBM growth comparison

In terms of recent top-line expansion, the ACN vs IBM growth comparison shows that both companies are experiencing solid, albeit relatively close, revenue increases. IBM slightly edges out Accenture with a year-over-year revenue growth rate of +7.6%, compared to ACN’s +7.4%. While this difference is marginal, it suggests that IBM has demonstrated slightly stronger momentum in expanding its sales figures over the past year. Both companies are operating in dynamic technology and consulting sectors, where demand for digital transformation, cloud computing, and AI solutions continues to fuel growth.

Looking beyond immediate revenue growth, the implied forward estimates, particularly from analyst price targets, indicate differing perceptions of future momentum. ACN has a consensus price target of $299.92, representing a substantial upside of +66.4% from its current price. In contrast, IBM’s consensus price target is $309.64, offering a more modest upside of +36.3%. This disparity suggests that while IBM has slightly higher trailing revenue growth, analysts project a greater potential for future stock price appreciation or a deeper undervaluation for Accenture. Investors focused on growth potential and future returns as estimated by market experts might find ACN’s outlook more appealing, despite IBM’s slightly higher recent revenue growth.

ACN vs IBM profitability

Examining ACN vs IBM profitability reveals a clear leader in terms of operational efficiency and converting revenue into profit. IBM demonstrates significantly stronger margins across the board compared to Accenture. IBM’s net margin stands at an impressive 15.61%, considerably higher than ACN’s 10.65%. This indicates that for every dollar of revenue, IBM retains a larger portion as net income, showcasing superior cost management and operational leverage. Furthermore, IBM’s EBITDA margin of 23.69% also comfortably surpasses ACN’s 16.8%, reinforcing its efficiency at the core operational level before accounting for depreciation and amortization.

While IBM leads in net and EBITDA margins, the Free Cash Flow (FCF) yield provides another dimension to profitability, focusing on cash generation relative to market capitalization. Here, ACN takes the lead with an FCF yield of 11.26%, which is almost double IBM’s 6.13%. This suggests that Accenture is generating more free cash flow per dollar of its stock price, an important metric for investors valuing strong cash generation and financial flexibility. Both companies report N/A% for Return on Equity (ROE), preventing a direct comparison on this specific equity profitability metric. Overall, while IBM is more profitable on a margin basis, ACN exhibits stronger free cash flow generation relative to its valuation.

Analyst ratings: ACN vs IBM

A deep dive into analyst ratings for ACN vs IBM reveals a distinct preference among Wall Street experts for Accenture. ACN is covered by 53 analysts, and a significant majority, 73.6%, have a “Buy” rating on the stock. This strong conviction translates into a consensus rating of “Buy” for Accenture, with an average price target of $299.92. This target represents a substantial upside potential of +66.4% from its current trading price of $180.26, suggesting that analysts see considerable room for appreciation in ACN’s stock value in the coming year.

In contrast, International Business Machines Corporation (IBM) garners a less enthusiastic response from the analyst community. Out of 50 analysts covering IBM, only 44.0% currently recommend a “Buy” rating. The overall consensus for IBM is a more cautious “Hold.” The average price target set by these analysts is $309.64, which still implies a healthy upside of +36.3% from its present price of $227.1. While this is a respectable projected gain, it is significantly lower than the upside projected for ACN. Clearly, analysts collectively prefer ACN, indicating higher confidence in its near-term performance and growth trajectory compared to IBM.

Should I buy ACN or IBM stock in 2026?

When considering whether should I buy ACN or IBM stock in 2026, growth-oriented investors face a nuanced choice. IBM demonstrates a marginally higher recent revenue growth rate of +7.6% compared to ACN’s +7.4%, indicating slightly stronger immediate top-line momentum. However, ACN boasts a significantly higher analyst price target upside of +66.4%, versus IBM’s +36.3%. This suggests that while IBM has slightly outperformed on recent revenue growth, analysts perceive greater future growth potential or undervaluation in Accenture’s stock price. Therefore, for investors prioritizing substantial potential stock appreciation based on expert forecasts, ACN might be the more compelling choice.

For value investors meticulously analyzing ACN vs IBM fundamentals and valuation, both companies present interesting, albeit different, propositions. ACN appears cheaper on traditional valuation multiples, with a P/E ratio of 14.48x compared to IBM’s 19.82x, and a P/B ratio of 3.56x against IBM’s 6.46x. This makes ACN the clearer choice for investors seeking a stock trading at lower current earnings and book value multiples. Conversely, if your valuation approach heavily relies on intrinsic value models like Discounted Cash Flow (DCF), IBM stands out with a remarkable DCF upside of +92.7%, significantly higher than ACN’s +16.9%. This suggests that IBM may be more deeply undervalued according to this forward-looking methodology, presenting a potential opportunity for long-term value plays.

Regarding income, both ACN and IBM are not primarily dividend stocks, offering relatively low yields in 2026. Accenture’s dividend yield of 0.04% is marginally higher than IBM’s 0.03%. Investors focused on substantial dividend income will likely find neither stock particularly attractive, as their primary appeal lies in growth and capital appreciation. Ultimately, the decision on should I buy ACN or IBM stock in 2026 hinges on an investor’s specific priorities: growth potential as seen by analysts (ACN), current valuation multiples (ACN), intrinsic value potential (IBM), or slight dividend edge (ACN). This is not investment advice.

More ACN and IBM comparisons

ACN full stock analysis · IBM full stock analysis · All stock comparisons

FAQ: ACN vs IBM